Bilateral parotid glands infection caused by Calmette-Guerin Bacillus after intravesical therapy for recurrent bladder cancer: a case report

Bilateral parotid glands infection caused by Calmette-Guerin Bacillus after intravesical therapy for recurrent bladder cancer: a case report

Bibliographic Details
Main Authors:	Eviatar Friedlander, Paula Martínez Pascual, Pedro Montilla de Mora, Bartolomé Scola Yurrita
Format:	Article
Language:	English
Published:	Elsevier
Series:	Brazilian Journal of Otorhinolaryngology
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942017000600726&lng=en&tlng=en

Similar Items

Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
by: Centola Michael, et al.
Published: (2007-05-01)

Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer
by: Masashi Miyazaki, et al.
Published: (2016-01-01)

Interstitial pneumonitis secondary to intravesical bacillus calmette-guerin for carcinoma in-situ of the bladder
by: Eric K. Diner, et al.
Published: (2004-10-01)

Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guérin for Bladder Cancer
by: Yuqing Liu, et al.
Published: (2019-01-01)

Intravesical bacillus Calmette-Guerin for bladder cancer: What is known? What is not? What is next?
by: Khaled Madbouly
Published: (2013-01-01)

Intravesical Bacillus Calmette-Guerin for Treatment of Refractory Interstitial Cystitis
by: Saeed Arasteh, et al.
Published: (2007-02-01)

Bladder Contracture – A Rare and Serious Side Effect of Intravesical Bacillus Calmette-Guérin Therapy
by: Cindy Garcia, et al.
Published: (2016-01-01)

Bilateral symmetrical corneal melting following intravesical Bacille Calmette-Guerin therapy for bladder carcinoma
by: Chandana Chakraborty, et al.
Published: (2012-01-01)

Bacillus Calmette–Guérin and Bladder Cancer
by: Azad H.A. Razack
Published: (2007-10-01)

Tuberculous prostatic abscess following intravesical bacillus Calmette-Guérin immunotherapy
by: Bin Wang, et al.
Published: (2019-09-01)

Disseminated Granulomatous Disease from Intravesical Instillation of Bacillus Calmette-Guerin
by: Sayed Ab. Reshad Ghafouri, et al.
Published: (2018-01-01)

Intravesical Gemcitabine versus Intravesical Bacillus Calmette–Guérin for the Treatment of Non-Muscle Invasive Bladder Cancer: An Evaluation of Efficacy and Toxicity
by: Thiru Prasanna, et al.
Published: (2017-11-01)

Is bladder tumor location associated with prostate cancer detection after intravesical bacillus Calmette-Guérin instillation?
by: Sungwoo Hong, et al.
Published: (2014-01-01)

Case report: Mycobacterium bovis orchitis post intravesical Bacillus Calmette Guerin
by: Mohammed Samannodi, et al.
Published: (2018-01-01)

New-onset guttate psoriasis following intravesical immunotherapy of Bacillus Calmette–Guerin
by: Chih-Tsung Hung, et al.
Published: (2012-09-01)

Is intravesical bacillus Calmette-Guerin safe and efficacious in steroid treated and immunocompromized patients
by: Santosh Kumar, et al.
Published: (2006-01-01)

A severe complication of intravesical bacillus Calmette-Guerin: An effect of different strains
by: Li Sian Low, et al.
Published: (2021-05-01)

Molecular networks discriminating mouse bladder responses to intravesical bacillus Calmette-Guerin (BCG), LPS, and TNF-α
by: Dozmorov Igor, et al.
Published: (2008-02-01)

Role of Aspirin in Patients with Bladder Cancer Receiving Intravesical Bacillus Calmette-Guerin: A Prospective, Observational Study
by: Rupesh Gupta, et al.
Published: (2017-10-01)

Difference in recurrence frequencies of non-muscle-invasive-bladder tumors depending on optimal usage of intravesical immunotherapy of bacillus Calmette-Guérin
by: Milošević Radovan, et al.
Published: (2015-01-01)

Bacillus Calmette-Guerin in the management of superficial bladder cancer
by: Rakesh Kapoor, et al.
Published: (2008-01-01)

Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Abridged summary of the Cochrane Review
by: Stefanie Schmidt, et al.
Published: (2020-07-01)

The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: A pilot study
by: Pawan Vasudeva, et al.
Published: (2008-01-01)

Tuberculous Granuloma in the Scrotal Skin After Intravesical Bacillus Calmette-Guerin Therapy for Bladder Cancer: A Case Report
by: Hiroshi Shimura, et al.
Published: (2017-02-01)

Tuberculous Prostatic Abscess with Prostatorectal Fistula after Intravesical Bacillus Calmette-Guérin Immunotherapy
by: Jeong Ho Eom, et al.
Published: (2016-09-01)

A case of renal granulomatosis with polyangiitis following intravesical bacillus Calmette-Guérin therapy
by: Yosra Selmi, et al.
Published: (2018-01-01)

Penile lesion with inguinal adenopathy after intravesical Bacillus Calmette-Guerin instillation therapy
by: Guven Aslan, et al.
Published: (2013-01-01)

Granulomas do pênis: uma complicação rara da terapia intravesical com Bacilo Calmette-Guérin Granulomas of the penis: a rare complication of intravesical therapy with Bacillus Calmette-Guerin
by: Sara Isabel Alcântara Lestre, et al.
Published: (2011-08-01)

Combination of Intravesical Bacille Calmette-Guérin and Chemotherapy vs. Bacille Calmette-Guérin Alone in Non-muscle Invasive Bladder Cancer: A Meta-Analysis
by: Di Huang, et al.
Published: (2019-03-01)

Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993)
by: Andreas Bohle
Published: (2011-04-01)

Poncet’s disease after the intravesical instillation of Bacillus Calmette–Guérin (BCG): a case report
by: Paula Cíntia Machado Sampaio, et al.
Published: (2017-08-01)

Penile tuberculosis following intravesical Bacille Calmette-Guérin immunotherapy
by: Anadi Roy Chowdhury, et al.
Published: (2013-01-01)

Weekly intravesical bacillus Calmette-Guerin (BCG) alternating with epirubicin in Ta and T1 urothelial bladder cancer: An approach to decrease BCG toxicity
by: Bedeir Ali-El-Dein, et al.
Published: (2013-01-01)

Intravesical Bacillus Calmette–Guérin Treatment for T1 High-Grade Non-Muscle Invasive Bladder Cancer with Divergent Differentiation or Variant Morphologies
by: Makito Miyake, et al.
Published: (2021-05-01)

A case of infectious thoracic aortic aneurysm after intravesical Bacillus Calmette-Guérin instillation therapy for a superficial bladder cancer
by: Shigeki Koterazawa, et al.
Published: (2021-05-01)

Granulomatous hepatitis, choroiditis and aortoduodenal fistula complicating intravesical Bacillus Calmette-Guérin therapy: Case report
by: Antoine John, et al.
Published: (2011-09-01)

Combined Application of Nivolumab and Intravesical Bacillus Calmette-Guérin Led to Acute-Onset Type 1 Diabetes
by: Koichi Fujiu, et al.
Published: (2019-06-01)

Two-stage posterior decompression and fusion for tuberculous spondylitis after intravesical bacillus Calmette-Guerin instillation
by: Hiroki Ohata, et al.
Published: (2021-01-01)

Prosthetic Joint Infection due to Mycobacterium bovis after Intravesical Instillation of Bacillus Calmette-Guerin (BCG)
by: Eric Gomez, et al.
Published: (2009-01-01)

Imaging appearance of granulomatous disease after intravesical Bacille Calmette-Guerin (BCG) treatment of bladder carcinoma
by: Adilson Prando
Published: (2009-10-01)